Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...
Only 34 of 79 websites stated that compounded drugs were not FDA approved; 39 websites did not report adverse effects, warnings.
Medpage Today on MSN5d
Online Sellers of Compounded GLP-1s Often Don't Mention RisksHalf of the websites (49.4%) failed to mention risks including adverse effects, warnings and precautions, and ...
More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
BofA Securities maintained an Underperform rating on shares of Hims & Hers Health, Inc. (NYSE:HIMS) with a steady price ...
The latest attempt focuses on liraglutide, an older ... Some dosage strengths of both Victoza and Saxenda are included on the FDA's shortages list, mainly due to pressures on Novo Nordisk's ...
First liraglutide generic cleared for diabetes Finally, the FDA has cleared the first generic of Novo Nordisk's once-daily injectable GLP-1 agonist Victoza (liraglutide), used to treat type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback